Application of cinnamic acid substance in relieving lipid accumulation and senescence of glucose-induced nematodes

By applying hydroxycinnamic acid, the problem of cinnamic acid-like substances in alleviating glucose-induced lipid accumulation and aging in *C. elegans* was solved, achieving the effect of significantly reducing lipid accumulation and prolonging lifespan.

CN118924722APending Publication Date: 2024-11-12NANJING UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202310518080.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-09
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

There is currently no research on the use of cinnamic acid compounds to alleviate glucose-induced lipid accumulation and aging in *C. elegans*, and there is a lack of exploration into their application.

Method used

Using p-hydroxycinnamic acid as a positive compound, the effects of p-hydroxycinnamic acid on glucose-induced high-lipid nematodes were studied experimentally. It was found that a concentration of 50 μM p-hydroxycinnamic acid could reduce lipid accumulation in nematodes and prolong their lifespan.

Benefits of technology

50 μM p-hydroxycinnamic acid significantly reduced lipid accumulation in glucose-induced *C. elegans*, increased its average survival rate by 22%, and delayed the aging process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924722A_ABST
    Figure CN118924722A_ABST
Patent Text Reader

Abstract

The invention relates to application of cinnamic acid substances in relieving lipid accumulation and senescence of glucose-induced nematodes, and belongs to the field of biology and medicine. The invention also discloses application of cinnamic acid substances in preparation of drugs for relieving glucose-induced nematode lipid accumulation and senescence, drugs for relieving glucose-induced lipid accumulation or prolonging life of human bodies, and food or drug additives for relieving glucose-induced lipid accumulation of human bodies. In addition, the invention further discloses a kit for studying lipid lowering and life prolonging of the high-lipid caenorhabditis elegans, and a positive compound in the kit is p-hydroxycinnamic acid. The invention proves that cinnamic acid substances can slow down glucose-induced nematode lipid accumulation and senescence to a certain extent.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biology and medicine, and specifically relates to the application of cinnamic acid substances in alleviating glucose-induced lipid accumulation and aging of nematodes and in preparing food or medicine additives for alleviating glucose-induced lipid accumulation in human bodies. Background Art

[0002] C. elegans is an animal that lives in temperate soil environments. Its life cycle consists of an egg stage, four larval stages (L1-L4) and an adult stage. C. elegans is an excellent model organism for the study of aging because of its small size, short life cycle, easy maintenance in the laboratory, and the availability of a complete genome. It is of great significance to use the C. elegans model to study new drugs that can delay aging and a series of human diseases. Research using nematodes as biological models has been verified in mammals and even humans, such as resveratrol and metformin.

[0003] Para-hydroxycinnamic acid is a cinnamic acid. However, no research has been found on the use of cinnamic acids to treat high glucose-induced Caenorhabditis elegans. Summary of the invention

[0004] The purpose of the present invention is to solve the deficiencies of the prior art and provide an application of cinnamic acid substances in alleviating glucose-induced lipid accumulation and senescence in nematodes and an application of cinnamic acid substances in preparing a food or pharmaceutical additive for alleviating glucose-induced lipid accumulation in humans.

[0005] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0006] The first aspect of the present invention provides the use of cinnamic acid substances in alleviating lipid accumulation and senescence of nematodes induced by glucose

[0007] Furthermore, the lipid accumulation mentioned is glucose-induced lipid accumulation.

[0008] The second aspect of the present invention provides a kit for studying lipid-lowering and life-extending of high-lipid nematodes, characterized in that it comprises a positive compound, wherein the positive compound is p-hydroxycinnamic acid.

[0009] The third aspect of the present invention provides a cinnamic acid substance for use in preparing a drug for alleviating glucose-induced lipid accumulation or prolonging life in the human body.

[0010] A fourth aspect of the present invention provides an application of cinnamic acid substances as food or pharmaceutical additives for preparing food or pharmaceutical additives for alleviating glucose-induced lipid accumulation in the human body.

[0011] The present invention uses p-hydroxycinnamic acid as an active ingredient and uses the model organism Caenorhabditis elegans to observe the effect of p-hydroxycinnamic acid on the life span of high-lipid nematodes induced by glucose. It is found that p-hydroxycinnamic acid at a concentration of 50 μM can reduce the lipid accumulation of nematodes induced by glucose, and the average survival rate of the 50 μM p-hydroxycinnamic acid intervention group is increased by 22%, which also shows that it can delay the aging process.

[0012] The p-hydroxycinnamic acid described in the present invention is a commercially available product, and the present invention is not limited thereto.

[0013] Compared with the prior art, the present invention has the following beneficial effects:

[0014] 1. The research of the present invention reveals the effects of cinnamic acid substances on the average survival rate and median life span of nematodes under conditions of high lipid accumulation induced by glucose: In the experiment, it was found that 50 μM p-hydroxycinnamic acid can prolong the life span of Caenorhabditis elegans induced by glucose and reduce its lipid accumulation.

[0015] 2. The present invention has discovered new uses for cinnamic acid substances and laid a foundation for the future development of new health foods or medicines. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 This is the survival curve of the group administered with different doses of p-hydroxycinnamic acid at 20°C of the present invention.

[0017] Figure 2 The present invention shows the effects of administration of different doses of hydroxycinnamic acid on lipid accumulation in the intestine of nematodes.

[0018] Figure 3 This is the effect of 50 μM p-hydroxycinnamic acid of the present invention on the accumulation of lipofuscin in nematodes.

[0019] Figure 4 The figure shows the effect of 50 μM p-hydroxycinnamic acid of the present invention on the ROS content in nematodes. DETAILED DESCRIPTION

[0020] To facilitate understanding of the present invention, the present invention will be described more comprehensively below with reference to the relevant drawings.

[0021] Those skilled in the art will appreciate that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the art or the product specifications are used. If the manufacturer of the materials or equipment used is not specified, they are all conventional products that can be purchased.

[0022] Experimental Example 1: Pharmacodynamics of p-hydroxycinnamic acid to prolong the life span of nematodes induced by glucose

[0023] 1. Materials

[0024] 1.1 Experimental Materials and Reagents

[0025] The nematode is Caenorhabditis elegans, wild type N2;

[0026] The nematode food is Escherichia coli (E.coli) OP50;

[0027] The reagents are: p-hydroxycinnamic acid; glucose; sodium chloride; dipotassium hydrogen phosphate; potassium dihydrogen phosphate; disodium hydrogen phosphate; magnesium sulfate; cholesterol; agar powder; tryptone; yeast powder; peptone; levamisole; dimethyl sulfoxide (DMSO); 5-fluorodeoxyuridine (FUDR); Oil Red O; and 2',7'-dichlorofluorescein diacetate (DCFH-DA).

[0028] Preparation of OP50 culture medium: Lysogeny Broth solid culture medium, LB is the main food source for OP50 survival, the culture medium contains trypsin, NaCl, yeast extract, agar, deionized water, cholesterol solution, MgSO4, PK buffer (pH = 6).

[0029] Prepare NGM medium: NGM (C.elegans Growth Media, NGM) medium contains peptone, NaCl, agar, deionized water, CaCl2, MgSO4, cholesterol solution, and phosphate buffer (KPI). Mix well and dispense into culture dishes. After cooling to room temperature, add fresh OP50, culture in a 37°C incubator overnight, and place in a 4°C refrigerator for later use.

[0030] 1.2 Instruments

[0031] ZXSD-81430-biochemical incubator, SMZ-168-dissecting microscope, D-1-high pressure sterilizer, DK-420-electric constant temperature water bath, fluorescence microscope.

[0032] 2. Methods

[0033] 2.1 Experimental Grouping

[0034] Wild-type Caenorhabditis elegans N2 was selected to eat live (E. coil) OP50, and a life span measurement experiment was performed at 20°C. The control group was 0 μM p-hydroxycinnamic acid (containing 1% mass concentration of DMSO solvent), the intervention concentrations of p-hydroxycinnamic acid in the drug-treated group were 50 μM, 0 μM (containing 1% DMSO solvent), and the glucose concentration was 5 mM.

[0035] (1) Cultivation of Caenorhabditis elegans

[0036] In a clean room, cool the freshly prepared NGM medium containing OP50 for 5 minutes. Using a dissecting microscope, pick three L1 or L2 nematodes and place them in the NGM medium, which is then placed in a 20°C incubator.

[0037] (2) Synchronization

[0038] The egg-laying nematodes that have developed to day 1 are placed in culture medium and cultured overnight. After 10 hours, the mother worms are removed to obtain nematodes of the same period. The nematodes are cultured in a 20°C incubator until they develop into young adults and then transferred.

[0039] (3) Lifespan observation

[0040] Pick synchronized L4 nematodes to each group of standard nematode NGM culture medium, 120 per group, 30 per plate. Count the number of nematode survival days from the moment of transfer, and the day of transfer is recorded as day 0 of the lifespan experiment. Record the number of nematode deaths every day. Nematode death criteria: loss of movement ability, no response to multiple touches. Statistical comparison of average lifespan and maximum lifespan (average lifespan of the last 10 nematodes surviving in each group of nematodes) was performed.

[0041] (4) Drug addition

[0042] The drug was added directly to the OP50 bacteria, that is, p-hydroxycinnamic acid dissolved in DMSO solution was added to the OP50 bacterial solution to make the final concentration as follows: Figure 1 Final concentrations as indicated in .

[0043] 3. Results Analysis

[0044] Statistical analysis of lifespan experiments was performed using an online application (OASIS; sbi.postech.ac.kr / oasis). The above experiments were repeated three times independently.

[0045] The results of the 20℃ experiment showed that the average lifespan of the control group (0μM p-hydroxycinnamic acid) was 20 days, and the maximum lifespan was 32 days. The average lifespan of the glucose-induced group (0μM p-hydroxycinnamic acid) was 16 days, and the maximum lifespan was 23 days. The average lifespan of the glucose-induced group (50μM p-hydroxycinnamic acid) was 19 days, and the maximum lifespan was 28 days. Among them, 50μM p-hydroxycinnamic acid extended the average lifespan of nematodes by 22% (P<0.001) ( Figure 1 ). The results showed that at 20°C, 50 μM p-hydroxycinnamic acid significantly prolonged the lifespan of wild-type Caenorhabditis elegans.

[0046] Experimental Example 2: Effect of different doses of hydroxycinnamic acid on lipid accumulation in the intestine of nematodes

[0047] Nematode treatment: After synchronization, young adult nematodes were transferred to the corresponding control and treatment culture dishes, ensuring that each dish contained 20 nematodes. At the same time, before transfer, FUDR, which inhibits the hatching of nematode eggs, was added to each dish and spread as evenly as possible to prevent interference from the offspring nematodes. After 48 hours of treatment, the nematodes were stained with Oil Red O.

[0048] Staining treatment: The nematodes to be stained were washed with PBST buffer into an EP tube, and the washing was repeated at least twice to remove OP50. After washing, the supernatant was discarded, isopropanol was added and placed on a vortex mixer for treatment, the supernatant was discarded, Oil Red O dye was added, and the tube was placed on a decolorizing shaker to avoid light for staining, the dye was discarded by centrifugation, PBST buffer was added and placed on a decolorizing shaker to avoid light for decolorization, the supernatant was discarded by centrifugation, and the worm liquid was aspirated onto a coverslip for preparation. Pictures were taken with a fluorescence microscope, and Image J software was used to quantitatively analyze the abdominal intestinal fat of the nematodes.

[0049] like Figure 2 As shown, Figure 2 The fat content in the intestine of the nematodes in the control group, the glucose-induced group and the glucose-administered group after administration of the present invention to the nematodes was found to be 4% lower than that in the glucose-induced high-lipid group (P < 0.001) ( Figure 2 ).

[0050] Experimental Example 3: Experiment on the effect of 50 μM p-hydroxycinnamic acid on lipofuscin accumulation in nematodes.

[0051] When C. elegans develops into young adults, it is transferred to the corresponding control and treatment culture dishes for treatment. At least 20 C. elegans are selected for each group. FUDR is added to the culture dishes of each group before transfer to prevent the offspring nematodes from affecting the experiment. After 5 days of treatment, the nematodes are picked and placed on a coverslip containing levamisole solution for anesthesia and covered with agarose. Fluorescence images are taken using a fluorescence microscope, and the data are processed using Image J software. Figure 3 As shown, Figure 3 This is a graph showing the lipofuscin content in the control group, glucose-induced group and glucose-administered group after administration of the present invention to Caenorhabditis elegans. It was found that compared with the high-lipid group induced by glucose, 50 μM p-hydroxycinnamic acid reduced the accumulation of lipofuscin in the nematode by 72% (P < 0.001) ( Figure 3 ).

[0052] Experimental Example 4: Experiment on the effect of 50 μM p-hydroxycinnamic acid on the ROS content in nematodes.

[0053] When C. elegans develops into young adults, it is transferred to the corresponding control and treatment culture dishes for treatment. At least 20 C. elegans are taken for each group. At the same time, before transfer, FUDR, which inhibits the hatching of nematode eggs, is added to each dish and spread as evenly as possible to prevent interference from the offspring nematodes. After 48 hours of treatment, the cells are stained with DCFH-DA solution, anesthetized with levamisole, and sliced ​​with agarose. The cells are observed under a fluorescence microscope, and the images are processed using Image J software. Figure 4 As shown, Figure 4 The graph of the ROS content in the control group, glucose-induced group and glucose-administered group after administration of the present invention to Caenorhabditis elegans shows that compared with the glucose-induced high-lipid group, 50 μM p-hydroxycinnamic acid reduced the ROS content in the nematode by 22% (P < 0.001) ( Figure 4 ).

[0054] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A use of cinnamic acid derivatives in alleviating glucose-induced lipid accumulation and aging of nematodes, characterized in that: Cinnamic acid derivatives were dissolved in dimethyl sulfoxide to form a solution, and the solution was administered to glucose-induced Caenorhabditis elegans by feeding.

2. The use according to claim 1, characterized in that: The high-sugar induction method for nematodes is to add glucose into liquid NGM at a constant temperature of 40°C and stir it evenly to make an NGM plate. The NGM plate containing nematodes seeded with bacteria is placed in an incubator and maintained at 20°C; the glucose induction group and p-hydroxycinnamic acid treatment method is to drop the p-hydroxycinnamic acid mixture into the bacterial moss on the NGM plate containing glucose.

3. The use of a cinnamic acid derivative according to claim 1 in alleviating lipid accumulation and senescence of glucose-induced nematodes, characterized in that: A cinnamic acid derivative is used as a kit for reducing lipid and prolonging life of high-lipid nematodes, comprising a positive compound, wherein the positive compound is p-hydroxycinnamic acid.

4. The use of a cinnamic acid derivative according to claim 1 in alleviating glucose-induced lipid accumulation and senescence of nematodes, characterized in that: A use of cinnamic acid derivatives in preparing drugs for alleviating glucose-induced lipid accumulation or prolonging life span in human body.

5. The use of a cinnamic acid derivative according to claim 1 in alleviating glucose-induced lipid accumulation and senescence of nematodes, characterized in that: The invention discloses an application of cinnamic acid derivatives as food or medicine additives for preparing food or medicine additives for alleviating glucose-induced lipid accumulation in human body.

Citation Information

Cited By

  • Application of cinnamyl cinnamate in preparation of anti-aging and life-prolonging product

    CN119925335A